Endometrial Cancer Genomics - Cancer PHGKB -

Main|Search|PHGKB




Last Posted: May 05, 2019

---

• Genome-wide association studies of endometrial cancer: Latest developments and future directions.
  O'Mara Tracy A et al. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2019 Apr
• Systematic characterization of germline variants from the DiscovEHR study endometrial carcinoma population
  JE Miller et al, BMC Medical Genomics, May 2019
• [A prospective cohort study about the screening tests of mismatch repair protein and clinical criteria for Lynch syndrome associated endometrial carcinoma].
  Chao X P et al. Zhonghua yi xue za zhi 2019 Apr 99(15) 1178-1183
• Clinical and Cost Effectiveness of Two “New” Lynch Syndrome Case Finding Protocols in Endometrial Cancer Population Contrasted with the IHC-based Protocol
  JM Gudgeon et al, BioRXIV, April 18, 2019
• Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists.
  Soslow Robert A et al. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2019 Jan 38 Suppl 1S64-S74
• Screening for Lynch Syndrome by Immunohistochemistry of Mismatch Repair Proteins: Significance of Indeterminate Result and Correlation With Mutational Studies.
  Sarode Venetia R et al. Archives of pathology & laboratory medicine 2019 Mar
• A Micro-Costing Study of Screening for Lynch Syndrome-Associated Pathogenic Variants in an Unselected Endometrial Cancer Population: Cheap as NGS Chips?
  Ryan Neil A J et al. Frontiers in oncology 2019 961
• Impact of molecular testing in clinical practice in gynecologic cancers.
  Huang Marilyn et al. Cancer medicine 2019 Mar
• [Lynch Syndrome:Report of One Case and Literature Review].
  Guo Yan-Ping et al. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 2018 Jun 40(3) 432-435
• A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.
  Wu Yu-Shen et al. Gene 2019 Feb

more